HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Tofa For UC
This study is now recruiting.
The purpose of this research study is to help us understand how well tofacitinib works as a treatment for ulcerative colitis or indeterminate colitis in pediatric patients. We are looking to enroll, males or females ages 6 to 21 years old with a diagnosis of ulcerative colitis or indeterminate colitis who have started tofacitinib therapy prescribed by their primary gastroenterologist within the past 2 weeks or will be starting tofafacitinib within 1 month.
Who Do I Contact?
If you are interested in participating in the study or want to learn more please contact our study team at criscim [at] chop.edu or 267-693-6568.
Eligibility & Criteria
IRB #:
20-017316
Official Title:
An Observational Study of the Natural History of Tofacitinib for Clinical Treatment of Severe Pediatric Ulcerative Colitis and Indeterminate Colitis
Study Phase:
Not Applicable
Eligible Age Range:
6 - 21 Years
Gender:
All
Study Categories:
Leader
